Approval · Notice of Compliance 19855 · 2017
ABSTRAL: Notice of Compliance 19855
Issued September 26, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19855
- Date
- September 26, 2017
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specificatio of the drug product tests
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABSTRAL | Not yet assigned | — |
Medicinal ingredients
- FENTANYL CITRATE 100 MCG per TAB
- FENTANYL CITRATE 200 MCG per TAB
- FENTANYL CITRATE 300 MCG per TAB
- FENTANYL CITRATE 400 MCG per TAB
- FENTANYL CITRATE 600 MCG per TAB
- FENTANYL CITRATE 800 MCG per TAB